-
29 votes
-
Rapid UTI test that cuts detection time to forty-five minutes awarded Longitude prize – could herald sea change in antibiotic use by identifying correct treatments
26 votes -
mRNA melanoma vaccine halves the risk of death and recurrence
16 votes -
Scientists pinpoint driver of IBD and other disorders; work under way to adapt existing drugs
14 votes -
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
12 votes -
We still don’t know how to talk about Amy Winehouse. The expectations and perception around the ‘Back to Black’ movie reflect a sort of mean grief over the singer persisting to this day.
17 votes -
mRNA cancer vaccine reprograms immune system to tackle glioblastoma
12 votes -
The psychopharmacology of cannabis and its impact on mental health - a primer
13 votes -
Lemon-scented marijuana compound reduces weed’s ‘paranoia’ effect
17 votes -
US state North Carolina medical marijuana sales begin at Cherokee nation store
12 votes -
The hazy evolution of cannabis
3 votes -
Christiania, Copenhagen's hippie oasis, wants to rebuild without its illegal hashish market
11 votes -
How the entire country of Denmark became a company town – economists warn of "Nokia-style" overdependence on a single sector with Ozempic boom
4 votes -
US Food and Drug Administration issues report claiming marijuana has legitimate medical uses - proposes rescheduling
51 votes -
A pill to make exercise obsolete (2017)
19 votes -
Psilocybin therapy alters prefrontal and limbic brain circuitry in alcohol use disorder
17 votes -
How Chinese organized crime dominates America’s illicit marijuana market
12 votes -
The war on recovery: how the US is sabotaging its best tools to prevent deaths in the opioid epidemic
17 votes -
Cystic fibrosis breakthrough has given patients a chance to live longer
18 votes -
Single dose of clinical-grade LSD provides immediate and lasting relief from anxiety, wins approval for phase III trials
69 votes -
US prescription market hamstrung for nine days (so far) by ransomware attack
39 votes -
The cheapest cocaine on Earth?
9 votes -
A US drugmaker’s feud with the DEA is exacerbating the ADHD meds crisis
36 votes -
Finland used to have one of the highest suicide rates in the world – how the country halved it and saved countless lives
28 votes -
Niacin has long been a public health darling. But an excess could be bad for the heart, study suggests.
15 votes -
Researchers find response to ketamine depends on opioid pathways, but varies by sex
10 votes -
Research at the heart of a US lawsuit against the abortion pill has been retracted
28 votes -
EBay will pay $59 million settlement over pill presses sold online as US undergoes overdose epidemic
10 votes -
Why are antidepressants so popular in Iceland? | Mindset
6 votes -
Inside the world's highest tech prison - HMP Fosse Way
12 votes -
Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets
31 votes -
Can Denmark's world-beating drugs maker Novo Nordisk stay ahead after Wegovy propelled them into the big league?
8 votes -
Aripiprazole (Abilify and generic brands): risk of pathological gambling
14 votes -
How two US pharmacists figured out that oral phenylephrine decongestants don’t work
32 votes -
Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says
9 votes -
New lifesaving malaria vaccines need to be available now
7 votes -
The US Supreme Court will rule on limits to the use of Mifeprestone, a commonly used abortion medication
16 votes -
Whats a drug that you would never try?
For me its meth. I had an online friend who developed schizophrenia and addiction from it. As well as it just seeming unappealing to me I think the risk from using it are too much.
52 votes -
Semaglutide for weight loss
Has anyone tried it out? There's currently a preventative healthcare initiative going on in my country where they start screening people over 40 for chronic or potentially chronic conditions. I...
Has anyone tried it out? There's currently a preventative healthcare initiative going on in my country where they start screening people over 40 for chronic or potentially chronic conditions.
I went for my initial checkup with the doc today and, being juuuuust below morbid obesity with a BMI of 34, asked her about semaglutide as an adjunct to exercise controlling calorie intake. She's referring me to a weight loss clinic at my local public hospital where I can be assessed for suitability (If I'm not mistaken the clinic has hepatologists and endocrinologists on staff along with allied healthcare workers such as physios and nutritionists). This is great because it costs a bomb if I have to go private. The only wrinkle is that I'm oddly enough not diabetic or pre-diabetic so whether or not I'll qualify for socialised semaglutide is unclear but we live in hope.
I was wondering if any of you had tried any of the variants of semaglutide for obesity and what your experiences have been like.
18 votes -
Novo Nordisk suggested to senior UK government officials that they could “profile” benefit claimants – those who are most likely to return to the labour market
17 votes -
Denmark is building on the success of blockbuster drugs – the country's focus on reinvestment is feeding a stream of discovery
7 votes -
First malaria vaccine slashes early childhood mortality
12 votes -
Adderall risks: Much more than you wanted to know (2017)
35 votes -
Something is golden in the state of Denmark – can Novo Nordisk's success really be a problem for the Danish economy?
8 votes -
New pill helps COVID smell and taste loss fade quickly
19 votes -
What a striking new study of death in America misses
15 votes -
Woman denied medication for being of childbearing age
59 votes -
A closer look at Kowloon Walled City in Hong Kong, the most densely populated place that ever existed
40 votes -
Scottish officials approve UK’s first drug consumption room intended for safer use of illegal drugs
30 votes -
New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes...
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that caused the first SARS epidemic in 2002.
The studies in mice, rabbits and guinea pigs [...] found that the vaccine candidate provided a strong immune response against a range of coronaviruses by targeting the parts of the virus that are required for replication.
Professor Jonathan Heeney from Cambridge’s Department of Veterinary Medicine, who led the research, [said] “We wanted to come up with a vaccine that wouldn’t only protect against SARS-CoV-2, but all its relatives.”
18 votes